Dengue: a continuing global threat
By M. Guzmán, S. Halstead, H. Artsob, P. Buchy, J. Farrar, D. Gubler, E. Hunsperger, A. Kroeger, H. Margolis, E. Martínez and 5 more. Nature Reviews Microbiology, 2010
2,086 citations recorded by the source corpus.
Dengue fever and dengue haemorrhagic fever are important arthropod-borne viral diseases. Each year, there are ∼50 million dengue infections and ∼500,000 individuals are hospitalized with dengue haemorrhagic fever, mainly in Southeast Asia, the Pacific and the Americas. Illness is produced by any of the four dengue virus serotypes. A global strategy aimed at increasing the capacity for surveillance and outbreak response, changing behaviours and reducing the disease burden using integrated vector management in conjunction with early and accurate diagnosis has been advocated. Antiviral drugs and vaccines that are currently under development could also make an important contribution to dengue control in the future.
Subfields: Infectious Diseases, Public Health, Environmental and Occupational Health, Sociology and Political Science
View Paper: https://www.semanticscholar.org/paper/54ad34e9b41eebcf8635c1c34b1321513d75743d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
In Public Health, Environmental and Occupational Health
Citations in the corpus
- Neutrophil Extracellular Traps and Its Implications in Inflammation: An Overview (2017, background): “The incidence of dengue infections has increased in recent years (102); therefore, it is necessary to understand the mechanisms of host defense used to fight this pathogen.”
- Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells (2013, background): “Suaya JA, et al. (2009) Cost of dengue cases in eight countries in the Americas and Asia: A prospective study.”
- Dengue and severe dengue (2025, positive): “Not only is cross-protective immunity short-lived, but adaptive immune response to one DENV appears to increase the risk of severe secondary infection with a heterolo gous DENV (82).”
- Epidemiology of dengue: past, present and future prospects (2013, background): “13 Notably, in 2009, the Cape Verde archipelago had a large dengue outbreak involving more than 17,000 cases and linked to DENV-3.”
- Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection (2013, neutral): “Americas, Africa and the Mediterranean regions [58].”